MYWOT
Very poor
0%
Good
5%
MALICIOUS CONTENT INDICATORS
Nimbustx.com most likely does not offer any malicious content.
Secure connection support
HTTPS
ADULT CONTENT INDICATORS
Nimbustx.com most likely does not offer any adult content.
Audience
-
Time on site
01:52
AVG
-
Gender
Popular pages
- Nimbus
- Nimbus Therapeutics Presents New Data on Oral Allosteric TYK2 Inhibitor at American Chemical Society
- Nimbus Therapeutics Announces Closing of Takeda’s Acquisition of TYK2 Subsidiary – Nimbus
- Nimbus Therapeutics Presents Clinical Data from Phase 1b Study of Oral Allosteric TYK2 Inhibitor at
- Nimbus Therapeutics Announces First Patient Dosed in Phase 1/2 Study of a Highly Selective HPK1
- Nimbus Therapeutics Closes $125M Private Financing to Advance Clinical Programs in Autoimmune